S. Iwarson

发表

Management of Bacterial Meningitis and Septicaemia in Children: Role of Antibiotics, Immunoglobulins and Corticosteroids

S. Iwarson, 1990 .

Hepatitis B and Non‐A, Non‐B in a Swedish Blood Center during 10 Years of HBsAg Screening

G. Norkrans, S. Iwarson, A. Lindholm, 1980, Vox sanguinis.

Excellent Booster Response 4-6 y after a Single Primary Dose of an Inactivated Hepatitis A Vaccine

S. Iwarson, M. Lindh, L. Widerström, 2002, Scandinavian journal of infectious diseases.

Are we giving too many doses of hepatitis A and B vaccines?

S. Iwarson, 2002, Vaccine.

HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

H. Thomas, S. Iwarson, David Brown, 1986, Hepatology.

Hepatitis C: natural history of a unique infection.

G. Norkrans, S. Iwarson, R. Wejstål, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine.

S. Iwarson, M. Lindh, L. Widerström, 2006, Journal of travel medicine.

Hepatitis A and B in different groups of homosexuals

G. Löwhagen, S. Iwarson, G. Johannisson, 1980, Infection.

Recovery and turnover rate of hepatitis B immunoglobulin in volunteers.

S. Iwarson, M. Wahl, S. Hermodsson, 1983, Developments in biological standardization.

Cerebrospinal fluid concentrations of ampicillin in listeric meningitis.

S. Iwarson, Å. Svedhem, R. Svensson, 1978, The Journal of antimicrobial chemotherapy.

Transfusion transmitted non‐A, non‐B hepatitis

S. Iwarson, 1988, Acta anaesthesiologica Scandinavica. Supplementum.

Why the Scandinavian countries have not implemented universal vaccination against hepatitis B.

S. Iwarson, 1998, Vaccine.

Substantial decline of notified hepatitis B in major parts of Europe after 1985.

S. Iwarson, W. Jilg, T. Stroffolini, 1994, Scandinavian journal of infectious diseases.

The main five types of viral hepatitis: an alphabetical update.

S. Iwarson, 1992, Scandinavian journal of infectious diseases.

Clinical, epidemiological and prognostic aspects of hepatitis "non-A, non-B"--a comparison with hepatitis A and B.

G. Norkrans, S. Iwarson, G. Frösner, 1979, Scandinavian journal of infectious diseases.

Hepatitis B immune globulin in prevention of hepatitis B among hospital staff members.

S. Iwarson, J. Ahlmén, D. Selander, 1977, The Journal of infectious diseases.

CHILDREN OF FEMALE RENAL TRANSPLANT RECIPIENTS

S. Iwarson, I. Kjellmer, J. Ahlmén, 1981, Acta paediatrica Scandinavica.

Neutralization of Hepatitis B Virus Infectivity by a Murine Monoclonal Antibody: An Experimental Study in the Chimpanzee

H. Thomas, A. Goodall, S. Iwarson, 1985, Journal of medical virology.

Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases.

P. Lundin, S. Iwarson, J. Lindberg, 1979, Scandinavian journal of gastroenterology.

Trigger factors and HL-A antigens in chronic active hepatitis

P. Lundin, S. Iwarson, A. Lindholm, 1975, British medical journal.

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen.

H. Thomas, S. Iwarson, P. Snoy, 1985, Gastroenterology.

Symposium on Vaccination against Hepatitis B: Excerpts from a Pre-Congress Meeting in Connection with the 17th Meeting of the European Association for the Study of the Liver (EASL). Goteborg, Sweden, September 9, 1982

S. Iwarson, 1982 .

A prospective study of serum antibody responses to enterotoxinogenic Escherichia coli in Swedish travellers.

A. Svennerholm, S. Iwarson, M. Jertborn, 1988, Scandinavian journal of infectious diseases.

Serodiagnosis of viral hepatitis A by a solid-phase radioimmunoassay specific for IgM antibodies.

R. Purcell, C. Pannuti, S. Iwarson, 1981, Scandinavian journal of infectious diseases.

Long-term follow-up of the immune response to hepatitis B vaccine in patients with Down's syndrome

S. Iwarson, M. Wahl, S. Hermodsson, 1987 .

Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection.

S. Iwarson, M. Pignatelli, H. Thomas, 1987, Journal of hepatology.

The natural course of chronic hepatitis C.

S. Iwarson, 1994, FEMS microbiology reviews.

Clearance of hepatitis B e-antigen in chronic hepatitis B infection.

G. Norkrans, P. Lundin, S. Iwarson, 1982, Scandinavian journal of gastroenterology.

Failure of hepatitis B immune globulin to protect against exp infection in chimpanzees.

S. Iwarson, P. Snoy, M. Wahl, 1989, Journal of hepatology.

Incidence of Viral Hepatitis after Administration of Factor IX Concentrates

S. Iwarson, A. Teger‐Nilsson, H. Kjellman, 1976, Vox sanguinis.

Hepatitis B Antigen and Prevention of Post‐Transfusion Hepatitis B

S. Iwarson, A. Lindholm, L. Magnius, 1975, Vox sanguinis.

Chromatographic removal of hepatitis B virus from a factor IX concentrate

S. Iwarson, P. Snoy, R. Gerety, 1987, Transfusion.

Acute Hepatitis Non‐A, Non‐B following Administration of Factor VIII Concentrates

G. Norkrans, S. Iwarson, G. Frösner, 1981, Vox sanguinis.

Progression of hepatitis non-A, non-B to chronic active hepatitis: a histological follow-up of two cases.

P. Lundin, S. Iwarson, J. Lindberg, 1979, Journal of clinical pathology.

A histological follow-up oftwocases

P. Lundin, S. Iwarson, J. Lindberg, 1979 .

Serologic markers of hepatitis A and B in chronic active hepatitis.

S. Iwarson, B. Hansson, G. Frösner, 1978, Scandinavian journal of gastroenterology.

Non-A, non-B hepatitis: dead ends or new horizons?

S. Iwarson, 1987, British medical journal.

Mother to infant transmission of hepatitis C virus infection

G. Norkrans, S. Iwarson, R. Wejstål, 1990, Journal of medical virology.

Liver morphology in acute viral hepatitis related to the hepatitis B antigen

P. Lundin, S. Iwarson, S. Hermodsson, 1972, Journal of clinical pathology.

Cefadroxil once daily for three or seven days versus amoxycillin for seven days in uncomplicated urinary tract infections in women.

S. Iwarson, O. Paulsen, T. Sandberg, 1985, Scandinavian journal of infectious diseases.

Cefadroxil single-dose long and short therapy versus amoxicillin in female urinary tract infections.

S. Iwarson, O. Paulsen, T. Sandberg, 1982, The Journal of antimicrobial chemotherapy.

Multiple attacks of jaundice associated with repeated sulfonamide treatment.

P. Lundin, S. Iwarson, 2009, Acta medica Scandinavica.

Multiple attacks of hepatitis in drug addicts: biochemical, immunochemical, and morphologic characteristics.

P. Lundin, J. Holmgren, S. Iwarson, 1973, The Journal of infectious diseases.

Studies on viral hepatitis and hepatitis B (Australia) antigen.

S. Iwarson, 1973, Scandinavian journal of infectious diseases. Supplementum.

Estimation of symptomatic and asymptomatic Salmonella infections.

A. Svennerholm, S. Iwarson, M. Jertborn, 1990, Scandinavian journal of infectious diseases.

Subtypes of Hepatitis B Antigen in Blood Donors and Post-transfusion Hepatitis: Clinical and Epidemiological Aspects

P. Lundin, S. Iwarson, A. Lindholm, 1973, British medical journal.

The long-term outcome of hepatitis B

G. Norkrans, P. Lundin, S. Iwarson, 1976, Infection.

Prevention of neonatal hepatitis B infection.

G. Norkrans, S. Iwarson, 1978, British medical journal.

A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen.

P. Lundin, S. Iwarson, A. Lindholm, 1975, JAMA.

The clinical significance of increased plasma levels of liver-synthesized coagulation factors in liver disease.

S. Iwarson, R. Olsson, R. Arnman, 1977, Scandinavian journal of gastroenterology.

POST-EXPOSURE PROPHYLAXIS FOR HEPATITIS B: ACTIVE OR PASSIVE?

S. Iwarson, 1989, The Lancet.

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

B. McMahon, E. Keeffe, S. Iwarson, 1998, Hepatology.

Interferon treatment in acute hepatitis B infection with prolonged course.

G. Norkrans, S. Iwarson, E. Nordenfelt, 1980, Scandinavian journal of infectious diseases.

e antigen in acute hepatitis B.

G. Norkrans, S. Iwarson, L. Magnius, 1976, British medical journal.

Long-term Follow-up of Chronic Hepatitis Patients with HBsAg, HBeAg and Dane Particle Associated DIMA Polymerase in Serum

G. Norkrans, S. Iwarson, E. Nordenfelt, 1980 .

New approaches to hepatitis A and B vaccines

S. Iwarson, 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Hepatitis‐Associated Antigen and Antibody in Swedish Blood Donors: Relation to Liver Disease 1

P. Lundin, S. Iwarson, A. Lindholm, 1972, Vox sanguinis.

Hepatitis-Associated Antigen and Antibody in Swedish Blood Donors

S. Iwarson, A. Lindholm, S. Hermodsson, 1972 .

The changed epidemiology of hepatitis A infection in Scandinavia.

G. Norkrans, S. Iwarson, G. Frösner, 1978, Scandinavian journal of infectious diseases.

Long-term follow-up of chronic hepatitis patients with HBsAg, HBeAg and Dane particles associated DNA polymerase in serum.

G. Norkrans, S. Iwarson, E. Nordenfelt, 1980, Scandinavian journal of infectious diseases.

Rational use of hepatitis B immune globulin.

S. Iwarson, 1977, Scandinavian journal of infectious diseases.

How Should a Carrier of Hepatitis B Surface Antigen (HBsAg) be Cared for with Regard to Clinical Investigation, General Counseling and Occupational Restrictions?

S. Iwarson, L. Barker, H. Reesink, 1978, Vox sanguinis.

Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups.

S. Iwarson, F. Deinhardt, G. Frösner, 1979, American journal of epidemiology.

The epidemiological pattern of hepatitis A, B, and non-A, non-B in Sweden.

G. Norkrans, S. Iwarson, G. Frösner, 1978, Scandinavian journal of gastroenterology.

Determination of HBeAg by radioimmunoassay: prognostic implications in hepatitis B.

G. Norkrans, S. Iwarson, G. Frösner, 1979, Scandinavian journal of gastroenterology.

Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment.

S. Iwarson, Å. Svedhem, 1979, The Journal of antimicrobial chemotherapy.

Listeric meningitis in the non-compromised host

S. Iwarson, G. Lidin‐Janson, R. Svensson, 2005, Infection.

Tourist hepatitis, antibodies to hepatitis a virus and immune serum globulin prophylaxis

G. Norkrans, S. Iwarson, G. Frösner, 2005, Infection.

Multiple hepatitis attacks in drug addicts.

G. Norkrans, S. Iwarson, G. Frösner, 1980, JAMA.

Immune response to hepatitis B vaccination in the mentally retarded.

S. Iwarson, M. Wahl, S. Hermodsson, 1983, Scandinavian journal of infectious diseases. Supplementum.

Hepatitis non-A, non-B—is a retrovirus involved?

S. Iwarson, 1987 .

DETECTION OF REVERSE TRANSCRIPTASE ACTIVITY IN ASSOCIATION WITH THE NON-A, NON-B HEPATITIS AGENT(S)

S. Iwarson, W. Coleman, R. Gerety, 1984, The Lancet.

Ultrastructural and cytochemical study of hepatocytes and lymphocytes during experimental non-A, non-B infections in chimpanzees.

S. Iwarson, E. Tabor, Z. Schaff, 1985, Journal of experimental pathology.

Does Cohn‐fractionated Rh immune globulin transmit viral hepatitis?

S. Iwarson, A. Vietorisz, G. Rybo, 1985, Transfusion.

Intestinal villous atrophy in chronic active hepatitis.

S. Iwarson, C. Åhrén, J. Lindberg, 1979, Scandinavian journal of gastroenterology.

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine.

S. Iwarson, H. Käyhty, B. Claesson, 1999, Vaccine.

[A new serologic test makes it possible to diagnose hepatitis C].

G. Norkrans, S. Iwarson, A. Lindholm, 1990, Lakartidningen.

The clinical pictures of giant cell arteritis. Temporal arteritis, polymyalgia rheumatica, and fever of unknown origin.

B. Bengtsson, K. Alestig, S. Iwarson, 1980, Postgraduate medicine.

Activity of α-1,4-Glucosidase in Extrahepatic Cholestasis and Acute Viral Hepatitis

S. Iwarson, R. Gamklou, 1973 .

NON-A, NON-B HEPATITIS VIRUS

O. Schiraldi, S. Iwarson, T. Santantonio, 1985, The Lancet.

Sequential changes of the plasma-protein pattern in cases of hepatitis A.

C. Kindmark, S. Iwarson, C. Laurell, 1988, Upsala journal of medical sciences.

Humoral immunoreactivity in chronic active hepatitis: relation to HLA antigens.

S. Iwarson, B. Kaijser, A. Lindholm, 1979, International archives of allergy and applied immunology.

Hepatitis A booster vaccination: is there a need?

S Iwarson, Pierre Van Damme, B. McMahon, 2003, The Lancet.

Tourist hepatitis and gamma globulin prophylaxis.

S. Iwarson, K. Stenqvist, 1976, Scandinavian journal of infectious diseases.

Hepatitis-associated antigen (HAA) in acute viral hepatitis. Serological and clinical studies.

S. Iwarson, S. Hermodsson, 1971, Scandinavian journal of infectious diseases.

Strategies for immunization against invasive Haemophilus influenzae type b infection.

S. Iwarson, 1991, Vaccine.

Retrovirus‐like particles in hepatocytes of patients with transfusion‐acquired Non‐A, Non‐B hepatitis

G. Norkrans, S. Iwarson, Z. Schaff, 1985, Journal of medical virology.

Adverse reactions to intravenous administration of fusidic acid.

L. Olaison, S. Iwarson, L. Hultén, 1981, Scandinavian Journal of Infectious Diseases.

Patterns of immunoglobulins in acute viral hepatitis: relation to hepatitis-associated antigen.

J. Holmgren, S. Iwarson, 1972, The Journal of infectious diseases.

[A notable decrease of hepatitis B in Stockholm and Gothenburg but not in Malmö-Lund].

S. Iwarson, P. Haglind, 1989, Lakartidningen.

GENETIC FACTORS IN THE DEVELOPMENT OF CHRONIC ACTIVE HEPATITIS

S. Iwarson, A. Lindholm, J. Lindberg, 1977, The Lancet.

What type of travelers would benefit from combined vaccination against hepatitis A and B?

S. Iwarson, 1998, Journal of travel medicine.

Outcome of listeria monocytogenes infection in compromised and non-compromised adults

S. Iwarson, S. Larsson, 1979, Infection.

The delta agent in acute and chronic hepatitis B infection in Sweden.

G. Norkrans, S. Iwarson, S. Hermodsson, 1983, Scandinavian journal of gastroenterology.

Herpes zoster and hepatitis B: detection of Hepatitis B surface antigen in vesicle fluid.

G. Norkrans, S. Iwarson, A. Vahlne, 1981, Scandinavian journal of infectious diseases.

Outcome of kisteria monocytogenes Infection in Compromised and Non-Compromised Adults A Comparative Study of Seventy-Two Cases Summary

S. Iwarson, S. Larsson, 2005 .

Hepatitis B vaccination with short dose intervals — A possible alternative for post-exposure prophylaxis?

S. Iwarson, M. Wahl, S. Hermodsson, 1988, Infection.

Diverging policies for vaccination against hepatitis B.

S. Iwarson, 1992, Archives of virology. Supplementum.

World-wide strategies for immunization against invasive Haemophilus influenzae type b disease.

S. Iwarson, 1993, Vaccine.

Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.

S. Iwarson, H. Käyhty, B. Claesson, 1994, The Pediatric infectious disease journal.

The Impact of Donor Selection on Virus Transmission

S. Iwarson, 1985 .

Dose response study of an inactivated hepatitis A virus vaccine.

S. Iwarson, B. Claesson, R. Carlsson, 1993, Journal of hepatology.

Successful postexposure vaccination against hepatitis B in chimpanzees

S. Iwarson, P. Snoy, M. Wahl, 1988, Journal of medical virology.

Immune responses to hepatitis B vaccine in the mentally retarded.

S. Iwarson, M. Wahl, S. Hermodsson, 1983, The Journal of infection.

Dengue Fever in Travellers: An Increasing Problem

S. Iwarson, 1998, The Journal of the Royal College of Physicians of Edinburgh.

Coenzyme-B12 therapy in acute viral hepatitis.

S. Iwarson, J. Lindberg, 1977, Scandinavian journal of infectious diseases.

Immunisation against hepatitis A — active or passive?

S. Iwarson, 1996, Infection.

Intradermal versus subcutaneous immunization with typhoid vaccine

S. Iwarson, P. Larsson, 1980, Journal of Hygiene.